Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
44.33
+1.25 (2.90%)
Nov 25, 2025, 4:00 PM EST - Market closed
Phibro Animal Health Market Cap
Phibro Animal Health has a market cap or net worth of $1.8 billion as of November 25, 2025. Its market cap has increased by 88.78% in one year.
Market Cap
1.80B
Enterprise Value
2.51B
1-Year Change
88.78%
Ranking
Category
Stock Price
$44.33
Market Cap Chart
Since April 11, 2014, Phibro Animal Health's market cap has increased from $642.80M to $1.80B, an increase of 179.54%. That is a compound annual growth rate of 9.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 1.75B | 105.29% |
| Dec 31, 2024 | 850.60M | 81.36% |
| Dec 29, 2023 | 469.00M | -13.66% |
| Dec 30, 2022 | 543.20M | -34.32% |
| Dec 31, 2021 | 827.10M | 5.28% |
| Dec 31, 2020 | 785.60M | -21.79% |
| Dec 31, 2019 | 1.00B | -22.64% |
| Dec 31, 2018 | 1.30B | -3.54% |
| Dec 29, 2017 | 1.35B | 16.59% |
| Dec 30, 2016 | 1.15B | -2.11% |
| Dec 31, 2015 | 1.18B | -4.03% |
| Dec 31, 2014 | 1.23B | 91.19% |
| Apr 11, 2014 | 642.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |